Hong Kong, the Asia-Pacific leader in non-invasive cancer treatment
-
Hong Kong Pioneers Multimodal Focal Therapy for…
Read moreHong Kong – In a significant medical breakthrough, The Chinese University of Hong Kong (CUHK) has established itself as a pioneer in Asia by introducing and systematically evaluating multimodality focal…
-
Li Ka Shing Foundation Brings Groundbreaking No…
Read moreHong Kong has made medical history as the first region in Asia to deploy cutting-edge histotripsy technology for liver cancer treatment, following a landmark donation from the Li Ka Shing...
-
Hong Kong Establishes itself as Asian Pioneer i…
Read moreHONG KONG – Hong Kong has solidified its position as Asia’s leading center for innovative non-invasive cancer treatment, becoming the first region in Asia to deploy revolutionary Histotripsy technology for clinical…
Hong Kong’s advanced medical technology delivering breakthrough non-invasive tumour ablation
-
Histotripsy for Liver Tumors
Read moreA completely non-invasive treatment that uses focused ultrasound waves to break down liver tumours without any incisions or needles. This approach avoids surgical wounds and significantly reduces risks such as bleeding, infection, and long recovery times.
-
Bronchoscopic Microwave Ablation (BMA) for Lungs
Coming soonA precise, minimally invasive technique that uses controlled microwave energy delivered through a bronchoscope to destroy lung tumour tissue. This protects surrounding organs while offering accurate tumour targeting and quicker recovery.
-
Multi-modality Focal Therapy for Prostate Cancer
Coming soonA combination of advanced, tissue-sparing technologies that treat prostate cancer with no surgical cuts and minimal impact on healthy tissue. Patients benefit from fewer side effects, faster healing, reduced discomfort, and a quicker return to normal life.
